Armstrong L, Thickett D R, Christie S J, Kendall H, Millar A B
Lung Research Group, University of Bristol Department of Hospital Medicine, Division of Medicine, Bristol, United Kingdom.
Am J Respir Cell Mol Biol. 2000 Jan;22(1):68-74. doi: 10.1165/ajrcmb.22.1.3728.
Membrane-associated tumor necrosis factor (mTNF) has recently been shown to induce inflammatory cellular responses previously attributed to the soluble form. The present study measures for the first time the expression and function of mTNF on the surface of alveolar macrophages (AMs) to determine whether it is associated with the development of acute respiratory distress syndrome (ARDS). TNF expression was determined by flow cytometry, and the function of mTNF on the surface of AMs was determined by an in vitro cytotoxicity assay. Tumor necrosis factor (TNF)-alpha bioactivity was measured by bioassay. Soluble TNF receptor (TNFR) protein and messenger RNA (mRNA) expression were measured by enzyme-linked immunosorbent assay and reverse transcriptase/polymerase chain reaction, respectively. Increased detection of mTNF was observed on the surface of AMs derived from subjects with ARDS (mean percentage increase in fluorescence 22.30 +/- 3.50% for subjects with ARDS compared with 7.09 +/- 1.70% for At Risk subjects [P < 0.003]). mTNF cytotoxicity in the bioassay positively correlated with the mTNF expression determined by flow cytometry (r(2) = 0.97). Although there was increased mTNF expression and cytotoxic function in ARDS, there was no significant increase in soluble TNF expression in the bronchoalveolar lavage fluid or the AM supernatants. Lower levels of CD120b-soluble TNFR were detected in the AM supernatants derived from subjects with ARDS compared with At Risk (mean 0.264 +/- 0.058 versus 0.593 +/- 0.143 ng/ml, respectively [P < 0.05]). By contrast, there was increased CD120b mRNA expression in AMs derived from subjects with ARDS (P < 0.03), suggesting that increased surface expression of this receptor may be important in mediating the signal of mTNF. These data demonstrate for the first time the presence of functionally active mTNF on the surface of AMs in ARDS and highlight a potential mechanism for TNF-mediated lung injury.
膜相关肿瘤坏死因子(mTNF)最近被证明可诱导先前归因于可溶性形式的炎症细胞反应。本研究首次测量了肺泡巨噬细胞(AMs)表面mTNF的表达和功能,以确定其是否与急性呼吸窘迫综合征(ARDS)的发生有关。通过流式细胞术测定TNF表达,通过体外细胞毒性试验测定AMs表面mTNF的功能。通过生物测定法测量肿瘤坏死因子(TNF)-α生物活性。分别通过酶联免疫吸附测定和逆转录/聚合酶链反应测量可溶性TNF受体(TNFR)蛋白和信使核糖核酸(mRNA)表达。在ARDS患者来源的AMs表面观察到mTNF检测增加(ARDS患者荧光平均百分比增加22.30±3.50%,而高危患者为7.09±1.70%[P<0.003])。生物测定中mTNF细胞毒性与流式细胞术测定的mTNF表达呈正相关(r² = 0.97)。虽然ARDS中mTNF表达和细胞毒性功能增加,但支气管肺泡灌洗液或AMs上清液中可溶性TNF表达没有显著增加。与高危患者相比,ARDS患者来源的AMs上清液中检测到的CD120b可溶性TNFR水平较低(分别为平均0.264±0.058与0.593±0.143 ng/ml[P<0.05])。相比之下,ARDS患者来源的AMs中CD120b mRNA表达增加(P<0.03),表明该受体表面表达增加可能在介导mTNF信号中起重要作用。这些数据首次证明ARDS患者AMs表面存在功能活跃的mTNF,并突出了TNF介导的肺损伤的潜在机制。